Phase I study of ifosfamide/doxorubicin in metastatic breast cancer.

被引：0
|
作者：
Aziz, Z [1 ]
Sana, S [1 ]
Sherazi, J [1 ]
Ilyas, N [1 ]
机构：
[1] Allama Iqbal Med Coll, Dept Oncol, Lahore, Pakistan
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
153
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Phase I study of liposomal doxorubicin (Caelix) and docetaxel as first line treatment in patients with metastatic breast cancer.
    Morabito, A
    Fanelli, M
    Gilberti, S
    Vitale, S
    Arena, MG
    Biondi, E
    Gattuso, D
    Massidda, B
    Gasparini, G
    ANNALS OF ONCOLOGY, 2000, 11 : 42 - 42
  • [2] Phase I study of liposomial doxorubicin (Caelix) and docetaxel as first line treatment in patients with metastatic breast cancer.
    Gasparini, G
    Morabito, A
    Fanelli, M
    Gilberti, S
    Vitale, S
    Arena, MG
    Biondi, E
    Gattuso, D
    Massidda, B
    ANNALS OF ONCOLOGY, 2000, 11 : 28 - 28
  • [3] Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.
    Yuan, Yuan
    Ge, Xuan
    Yost, Susan Elaine
    Lee, Jin Sun
    Frankel, Paul Henry
    Ruel, Christopher
    Cui, Yujie
    Murga, Mireya
    Tang, Aileen
    Martinez, Norma
    Karimi, Misagh
    Somlo, George
    Mortimer, Joanne E.
    Waisman, James Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Dendritic cell vaccine for metastatic breast cancer. Phase I/II study
    Moviglia, Gustavo A.
    Gaeta, Carlos
    Varela, Gabriela
    Farina, Fablo
    Moya, Roberto
    Paes de Lima, Andrea
    Costanzo, Herman
    Maranon, Gonzalo
    Merino, Silvia
    Guerra, O. M.
    ANNALS OF ONCOLOGY, 2004, 15 : 40 - 40
  • [5] Phase I/II study of carboplatin, vinorelbine and capecitabine in metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cathcart, C
    Verschraegen, C
    Rabinowitz, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 57S - 57S
  • [6] Phase I of doxorubicin and ifosfamide association for first line advanced breast cancer (ABC)
    Cure, H
    van Praagh, I
    Charrier, S
    Kwiatkowski, F
    Ferriere, JP
    Chollet, P
    ANNALS OF ONCOLOGY, 1998, 9 : 24 - 25
  • [7] Phase II study of ifosfamide and mesna in patients with metastatic breast cancer
    Walters, RS
    Holmes, FA
    Valero, V
    Esparza-Guerra, L
    Hortobagyi, GN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 413 - 415
  • [8] Phase I trial of ixabepilone and vorinostat in metastatic breast cancer.
    Luu, Thehang H.
    Blanchard, Suzette
    Beumer, Jan Hendrik
    Anyang, Bean N.
    Somlo, George
    Mortimer, Joanne E.
    Hurria, Arti
    Yang, Lixin
    Yen, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.
    Clark, Amy Sanders
    O'Dwyer, Peter J.
    Heitjan, Daniel
    Lal, Priti
    Feldman, Michael D.
    Gallagher, Maryann
    Redlinger, Colleen
    Colameco, Christopher
    Lewis, David
    Zafman, Kelly
    Langer, Melissa
    Rosen, Mark Alan
    Gogineni, Keerthi
    Bradbury, Angela R.
    Domchek, Susan M.
    Fox, Kevin R.
    DeMichele, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
    Campos, S. M.
    Parker, L.
    Chen, W.
    Bunnell, C. A.
    Atkinson, T.
    Lee, J.
    Matulonis, U. A.
    Harris, L. N.
    Krasner, C. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 276S - 276S
12345